Douglas R. Carlson
Director of Finance/CFO at Avenge Bio, Inc.
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Michael Heffernan | M | 59 |
Avenge Bio, Inc.
 Avenge Bio, Inc. Pharmaceuticals: MajorHealth Technology Avenge Bio, Inc. is an oncology-focused biotechnology company based in the United States. The American company develops cell-based immunotherapeutic products for the treatment of solid tumors using its proprietary Lococyte™ platform. The platform delivers engineered cells to the local tumor environment, generating high concentrations of immune effector molecules in proximity to the tumor, which initiates a robust, local, and durable systemic immune response while avoiding toxicities associated with systemic immunotherapies. Avenge's most advanced product candidate, AVB-001, produces native IL-2 immunotherapy and is initially being studied in metastatic peritoneal cancers such as ovarian cancer. The company has additional pipeline candidates for the treatment of a wide range of cancers, including pancreatic, lung, and breast cancers. Avenge was founded in 2019 by Paul Kevin Wotton and Michael Thomas Heffernan, with Heffernan serving as CEO since incorporation. | 5 years |
| Paul Wotton | M | 63 |
Avenge Bio, Inc.
Avenge Bio, Inc. Pharmaceuticals: MajorHealth Technology Avenge Bio, Inc. is an oncology-focused biotechnology company based in the United States. The American company develops cell-based immunotherapeutic products for the treatment of solid tumors using its proprietary Lococyte™ platform. The platform delivers engineered cells to the local tumor environment, generating high concentrations of immune effector molecules in proximity to the tumor, which initiates a robust, local, and durable systemic immune response while avoiding toxicities associated with systemic immunotherapies. Avenge's most advanced product candidate, AVB-001, produces native IL-2 immunotherapy and is initially being studied in metastatic peritoneal cancers such as ovarian cancer. The company has additional pipeline candidates for the treatment of a wide range of cancers, including pancreatic, lung, and breast cancers. Avenge was founded in 2019 by Paul Kevin Wotton and Michael Thomas Heffernan, with Heffernan serving as CEO since incorporation. | - |
| Otello Stampacchia | M | 55 | 4 years | |
| Richard Wooster | M | 59 | 2 years | |
| Maria Koehler | M | 67 | 3 years | |
| Scott Morenstein | M | 48 |
Avenge Bio, Inc.
Avenge Bio, Inc. Pharmaceuticals: MajorHealth Technology Avenge Bio, Inc. is an oncology-focused biotechnology company based in the United States. The American company develops cell-based immunotherapeutic products for the treatment of solid tumors using its proprietary Lococyte™ platform. The platform delivers engineered cells to the local tumor environment, generating high concentrations of immune effector molecules in proximity to the tumor, which initiates a robust, local, and durable systemic immune response while avoiding toxicities associated with systemic immunotherapies. Avenge's most advanced product candidate, AVB-001, produces native IL-2 immunotherapy and is initially being studied in metastatic peritoneal cancers such as ovarian cancer. The company has additional pipeline candidates for the treatment of a wide range of cancers, including pancreatic, lung, and breast cancers. Avenge was founded in 2019 by Paul Kevin Wotton and Michael Thomas Heffernan, with Heffernan serving as CEO since incorporation. | - |
| Josh Richardson | M | 42 |
Avenge Bio, Inc.
Avenge Bio, Inc. Pharmaceuticals: MajorHealth Technology Avenge Bio, Inc. is an oncology-focused biotechnology company based in the United States. The American company develops cell-based immunotherapeutic products for the treatment of solid tumors using its proprietary Lococyte™ platform. The platform delivers engineered cells to the local tumor environment, generating high concentrations of immune effector molecules in proximity to the tumor, which initiates a robust, local, and durable systemic immune response while avoiding toxicities associated with systemic immunotherapies. Avenge's most advanced product candidate, AVB-001, produces native IL-2 immunotherapy and is initially being studied in metastatic peritoneal cancers such as ovarian cancer. The company has additional pipeline candidates for the treatment of a wide range of cancers, including pancreatic, lung, and breast cancers. Avenge was founded in 2019 by Paul Kevin Wotton and Michael Thomas Heffernan, with Heffernan serving as CEO since incorporation. | - |
| Omid Veiseh | M | - |
Avenge Bio, Inc.
Avenge Bio, Inc. Pharmaceuticals: MajorHealth Technology Avenge Bio, Inc. is an oncology-focused biotechnology company based in the United States. The American company develops cell-based immunotherapeutic products for the treatment of solid tumors using its proprietary Lococyte™ platform. The platform delivers engineered cells to the local tumor environment, generating high concentrations of immune effector molecules in proximity to the tumor, which initiates a robust, local, and durable systemic immune response while avoiding toxicities associated with systemic immunotherapies. Avenge's most advanced product candidate, AVB-001, produces native IL-2 immunotherapy and is initially being studied in metastatic peritoneal cancers such as ovarian cancer. The company has additional pipeline candidates for the treatment of a wide range of cancers, including pancreatic, lung, and breast cancers. Avenge was founded in 2019 by Paul Kevin Wotton and Michael Thomas Heffernan, with Heffernan serving as CEO since incorporation. | - |
| Samantha Vuksanic | F | - | 3 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Jeffrey Aronin | M | 56 |
Lundbeck, Inc.
 Lundbeck, Inc. Pharmaceuticals: MajorHealth Technology Part of Lundbeck Foundation, Lundbeck, Inc. is a pharmaceutical company that produces pharmaceutical preparations. The company is based in Paramus, NJ. The company was founded by Jeffrey S. Aronin. | 11 years |
| Laura Mozur | F | - |
FirstMark Capital LLC
 FirstMark Capital LLC Investment ManagersFinance FirstMark Capital LLC (FirstMark Capital) is venture capital firm founded by Rick Heitzmann and Amish Jani in 1996. The firm is headquartered in New York. | 5 years |
| Patrick Enright | M | 62 |
FirstMark Capital LLC
FirstMark Capital LLC Investment ManagersFinance FirstMark Capital LLC (FirstMark Capital) is venture capital firm founded by Rick Heitzmann and Amish Jani in 1996. The firm is headquartered in New York. | 4 years |
| Francisco F. Oliveira | M | - | - | |
| Doug Foster | M | - |
FirstMark Capital LLC
FirstMark Capital LLC Investment ManagersFinance FirstMark Capital LLC (FirstMark Capital) is venture capital firm founded by Rick Heitzmann and Amish Jani in 1996. The firm is headquartered in New York. | 1 years |
| Yasmine Christine Nainzadeh | F | - |
Trinity College (Connecticut)
| 4 years |
| Stephane Eric Bouvel | M | - |
Trinity College (Connecticut)
| 4 years |
| Nicholas Kernan Rafferty | M | - |
Trinity College (Connecticut)
| 4 years |
| Al Robichaud | M | 63 |
Lundbeck, Inc.
Lundbeck, Inc. Pharmaceuticals: MajorHealth Technology Part of Lundbeck Foundation, Lundbeck, Inc. is a pharmaceutical company that produces pharmaceutical preparations. The company is based in Paramus, NJ. The company was founded by Jeffrey S. Aronin. | 1 years |
| James Schiff | M | - |
Trinity College (Connecticut)
| 4 years |
| Peter C. Munsill | M | - |
Trinity College (Connecticut)
| 4 years |
| Rafe Coulbourn Quinn | M | - |
Trinity College (Connecticut)
| 4 years |
| Christopher C. Harris | M | - |
Trinity College (Connecticut)
| 4 years |
| Adrian Fadrhonc | M | - |
Trinity College (Connecticut)
| 4 years |
| Robert Brinberg | M | - |
Trinity College (Connecticut)
| 4 years |
| Thom H. Back | M | - |
Trinity College (Connecticut)
| 4 years |
| Peter C. Webel | M | - |
Trinity College (Connecticut)
| 4 years |
| Elizabeth J. Welsh | F | - |
Trinity College (Connecticut)
| 4 years |
| Ernesto Anguilla | M | - |
Trinity College (Connecticut)
| 4 years |
| Kristi M. Hillyer | F | - |
Trinity College (Connecticut)
| 4 years |
| Greg Kern | M | - |
Trinity College (Connecticut)
| 4 years |
| Matt DeRosa | M | - |
Trinity College (Connecticut)
| 4 years |
| Jeff Del Carmen | M | 53 |
Lundbeck, Inc.
Lundbeck, Inc. Pharmaceuticals: MajorHealth Technology Part of Lundbeck Foundation, Lundbeck, Inc. is a pharmaceutical company that produces pharmaceutical preparations. The company is based in Paramus, NJ. The company was founded by Jeffrey S. Aronin. | 5 years |
| Jamie Evans | M | - |
Trinity College (Connecticut)
| 4 years |
| Kathryn Whyte | F | - |
Trinity College (Connecticut)
| 4 years |
| Douglas J Kisielius | M | - |
Trinity College (Connecticut)
| 4 years |
| Jon Selib | M | - |
Trinity College (Connecticut)
| 4 years |
| Britt deVeer | M | - |
Trinity College (Connecticut)
| 4 years |
| Teddy Schiff | M | - |
Trinity College (Connecticut)
| 4 years |
| Sergio Santillana | M | 61 | 4 years | |
| Salma Gaya | F | - |
Trinity College (Connecticut)
| 4 years |
| Michael Ferreira | M | - |
Trinity College (Connecticut)
| 4 years |
| Phillip Welshans | M | - |
Trinity College (Connecticut)
| 4 years |
| Romae Gordon | F | - |
Trinity College (Connecticut)
| 4 years |
| Justin B. Hudock | M | 47 |
Trinity College (Connecticut)
| 4 years |
| Fernando Borghese | M | 45 |
Trinity College (Connecticut)
| 4 years |
| Bradd Kern | M | - |
Trinity College (Connecticut)
| 4 years |
| Aleksandar Cook | M | - |
Trinity College (Connecticut)
| 4 years |
| Kevin Douglas Robertson | M | - |
Trinity College (Connecticut)
| 3 years |
| Brian D. Byrne | M | - |
Trinity College (Connecticut)
| 5 years |
| Josh Olson | M | - |
Trinity College (Connecticut)
| 4 years |
| William Price | M | - |
FirstMark Capital LLC
FirstMark Capital LLC Investment ManagersFinance FirstMark Capital LLC (FirstMark Capital) is venture capital firm founded by Rick Heitzmann and Amish Jani in 1996. The firm is headquartered in New York. | 3 years |
| Steven F. X. Murphy | M | - |
Trinity College (Connecticut)
| 12 years |
| Manali Doshi | M | - |
FirstMark Capital LLC
FirstMark Capital LLC Investment ManagersFinance FirstMark Capital LLC (FirstMark Capital) is venture capital firm founded by Rick Heitzmann and Amish Jani in 1996. The firm is headquartered in New York. | 1 years |
| Michael Cardullo | M | - |
FirstMark Capital LLC
FirstMark Capital LLC Investment ManagersFinance FirstMark Capital LLC (FirstMark Capital) is venture capital firm founded by Rick Heitzmann and Amish Jani in 1996. The firm is headquartered in New York. | 2 years |
| Nick Kapur | M | - |
FirstMark Capital LLC
FirstMark Capital LLC Investment ManagersFinance FirstMark Capital LLC (FirstMark Capital) is venture capital firm founded by Rick Heitzmann and Amish Jani in 1996. The firm is headquartered in New York. | 2 years |
| Justin Halsey Sughrue | M | - |
Trinity College (Connecticut)
| 4 years |
| Brett Rosenbaum | M | - |
Trinity College (Connecticut)
| 4 years |
| Dan O'Keefe | M | - |
FirstMark Capital LLC
FirstMark Capital LLC Investment ManagersFinance FirstMark Capital LLC (FirstMark Capital) is venture capital firm founded by Rick Heitzmann and Amish Jani in 1996. The firm is headquartered in New York. | 3 years |
| Brandon Dutt | M | - |
FirstMark Capital LLC
FirstMark Capital LLC Investment ManagersFinance FirstMark Capital LLC (FirstMark Capital) is venture capital firm founded by Rick Heitzmann and Amish Jani in 1996. The firm is headquartered in New York. | 1 years |
| Marc-Henri Galletti | M | - |
FirstMark Capital LLC
FirstMark Capital LLC Investment ManagersFinance FirstMark Capital LLC (FirstMark Capital) is venture capital firm founded by Rick Heitzmann and Amish Jani in 1996. The firm is headquartered in New York. | 4 years |
| Edward Baldini | M | - |
Trinity College (Connecticut)
| 1 years |
| Martin Hale | M | 52 |
FirstMark Capital LLC
FirstMark Capital LLC Investment ManagersFinance FirstMark Capital LLC (FirstMark Capital) is venture capital firm founded by Rick Heitzmann and Amish Jani in 1996. The firm is headquartered in New York. | 9 years |
| Sean Nolan | M | 56 |
Lundbeck, Inc.
Lundbeck, Inc. Pharmaceuticals: MajorHealth Technology Part of Lundbeck Foundation, Lundbeck, Inc. is a pharmaceutical company that produces pharmaceutical preparations. The company is based in Paramus, NJ. The company was founded by Jeffrey S. Aronin. | 1 years |
| Jim McNiel | M | 61 |
FirstMark Capital LLC
FirstMark Capital LLC Investment ManagersFinance FirstMark Capital LLC (FirstMark Capital) is venture capital firm founded by Rick Heitzmann and Amish Jani in 1996. The firm is headquartered in New York. | 9 years |
| Charles Perrin | M | 78 |
Trinity College (Connecticut)
| 8 years |
| William Reynolds | M | 75 |
Trinity College (Connecticut)
| 9 years |
| David Hirsch | M | 53 |
FirstMark Capital LLC
FirstMark Capital LLC Investment ManagersFinance FirstMark Capital LLC (FirstMark Capital) is venture capital firm founded by Rick Heitzmann and Amish Jani in 1996. The firm is headquartered in New York. | 1 years |
| Michael Katz | M | - |
FirstMark Capital LLC
FirstMark Capital LLC Investment ManagersFinance FirstMark Capital LLC (FirstMark Capital) is venture capital firm founded by Rick Heitzmann and Amish Jani in 1996. The firm is headquartered in New York. | 1 years |
| Barry N. Bycoff | M | 75 |
FirstMark Capital LLC
FirstMark Capital LLC Investment ManagersFinance FirstMark Capital LLC (FirstMark Capital) is venture capital firm founded by Rick Heitzmann and Amish Jani in 1996. The firm is headquartered in New York. | 2 years |
| Nick Allen | M | - |
Trinity College (Connecticut)
| 4 years |
| John Mansfield | M | - |
Trinity College (Connecticut)
| 3 years |
| Eric L. Biegelseisen | M | - |
Trinity College (Connecticut)
| 4 years |
| Ted Richardson | M | - |
Trinity College (Connecticut)
| 4 years |
| John Harnisch | M | - |
Trinity College (Connecticut)
| 4 years |
| Sam Chang | M | - |
Trinity College (Connecticut)
| 4 years |
| Stephen M. Burt | M | - |
Trinity College (Connecticut)
| 2 years |
| Kyle Griswold | M | - |
Trinity College (Connecticut)
| 4 years |
| Juliet Bakker | F | 62 |
FirstMark Capital LLC
FirstMark Capital LLC Investment ManagersFinance FirstMark Capital LLC (FirstMark Capital) is venture capital firm founded by Rick Heitzmann and Amish Jani in 1996. The firm is headquartered in New York. | 9 years |
| Daniel Kevin Cooney | M | - |
Trinity College (Connecticut)
| 4 years |
| James Russell Harlow | M | - |
Trinity College (Connecticut)
| 4 years |
| Daniel Wolfson | M | - |
FirstMark Capital LLC
FirstMark Capital LLC Investment ManagersFinance FirstMark Capital LLC (FirstMark Capital) is venture capital firm founded by Rick Heitzmann and Amish Jani in 1996. The firm is headquartered in New York. | - |
| Colin Lawrence Wilson-Murphy | M | - |
Trinity College (Connecticut)
| 4 years |
| Divya Gugnani | F | - |
FirstMark Capital LLC
FirstMark Capital LLC Investment ManagersFinance FirstMark Capital LLC (FirstMark Capital) is venture capital firm founded by Rick Heitzmann and Amish Jani in 1996. The firm is headquartered in New York. | - |
| George Childs | M | - |
FirstMark Capital LLC
FirstMark Capital LLC Investment ManagersFinance FirstMark Capital LLC (FirstMark Capital) is venture capital firm founded by Rick Heitzmann and Amish Jani in 1996. The firm is headquartered in New York. | 2 years |
| Aaron Goldstein | M | 41 |
Trinity College (Connecticut)
| 4 years |
| Craig Penna | M | - |
Trinity College (Connecticut)
| 4 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 86 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Douglas R. Carlson
- Personal Network
